Fermenta is one amongst just eight companies recognized as Indiaâ€™s Best Workplaces in Biotechnology & Pharmaceuticals. Fermenta has earned this recognition for creating a great workplace for all the employees and demonstrating its values in the five dimensions of building a High-Trust, High-Performance Culture â„˘ - credibility, respect, fairness, pride, and camaraderie.
Fermenta has successfully developed and filed patent application for enzymatic synthesis of Molnupiravir, an orally-active COVID-19 drug. This novel technology using green chemistry provides a sustainable, efficient and scalable method of manufacturing the drug.
Fermenta has been included in the Forbes India Hidden Gems 2019 list as one of just nine Indian companies that are on the verge of a growth momentum. Published in the issue dated 30th August 2019, the list â€śfeatures Indian companies that have already tasted a degree of success, and are now poised for bigger thingsâ€ť.
Our CEO, Mr. Prashant Nagreâ€™s views on â€śManaging in a VUCA Worldâ€ť, were featured in a special two-page supplement of Economic Times issue dated 20th August 2019. This supplement, titled Driving Change, focuses on views of leaders across industries who are a part of the India Leadership Council, and is circulated across India. The Economic Times is the worldâ€™s second most widely read English-language business newspaper with a readership of over 800,000.
Nutrition plays an important role in immune support and function. Our CEO, Mr Prashant Nagre, is passionate about improving the quality of life through the right nutrition and eliminating micronutrient deficiency that is one of the reasons behind immuno-deficiency.
Watch his views on the balance between nutrition and immunity in this video: Click here
Read his authored article on how the right nutrition can feed our immune system: Click here
Fermenta has been ranked as No. 9 in the Top Industrial Enzyme Companies 2019 list of Biospectrum India, a leading B2B media platform in the life sciences space. The September 2019 issue of Biospectrum, focusing on the industrial enzymes market, highlights the key players based on their achievements over the last few years, amongst which Fermenta is featured.
Fermenta features in:
Providing the world what it needs: The COVID-19 pandemic has renewed demand for nutritional products that improve immune function.Vitamin D is a vital nutrient with documented evidence for its important role in enhancing immunity as well as reducing the incidence, severity and risk of flu-like illness and pneumonia. Being the only manufacturer of Vitamin D3 in India, Fermenta expects to play an important role in maintaining immunity of communities in India and worldwide.
Ensuring health and safety: Even as we continue to manufacture our products, Fermenta’s commitment to the safety, health and well-being of our team remains our top priority. Across our locations, we put in place all necessary precautionary measures to ensure the safety of our employees. Looking ahead, we will continue to monitor the situation closely and act with urgency as per the guidance from health authorities.
To view our employee safety videos across locations, click on the links below:
Head Office, Thane: Click here
R&D Centre, Thane: Click here
Manufacturing Facility, Dahej: Click here
Manufacturing Facility, Kullu: Click here
Our commitment towards customers: In light of the gravity of the COVID-19 crisis, its pace and unprecedented level of disruption, Fermenta remained committed to all its stakeholders and took proactive measures to minimize disruptions to operations. Fermenta is in a continuous endeavor to bounce back from the global pandemic. Our dedicated employees and partners around the world will continue to do our best to serve our customers and the needs of our global community during these challenging times.